References
- Osawa Y., Tochigi B., Higashiyama T., Yarborough C., Nakamura T., Yamamoto T. Cancer Res. (Suppl) 1982; 42: 3299s–3306s
- Stedman R. L. Chem. Rev. 1968; 68: 153–207
- Osawa Y., Spaeth D. G. Biochemistry 1971; 10: 66–71
- Bensadoun A., Weinstein D. Analyt. Biochem. 1979; 40: 241–250
- Osawa Y., Fronckowiak M., Yoshida N., Higashiyama T. Steroids 1987; 50: 649–650
- Behrens B. Naunyn-Schmiedebergs Arch Exp. Path. Pharmak. 1929; 140: 237–256
- Osawa Y., U.S. Patent #4,829,059, 1989
- Tochigi M, Yarborough C., Tochigi B., Yoshida T., Takagi S. 65th Annual meeting of the Endocrine Society. 1983, abstract 458
- Chuman T. Japan Tobacco and Salt Public Corp. 1977; 119: 45–92, Research Report
- Snook M. E., Chortyk O. T., Arrendale R. F. Beiträge Zur Tabakforschung International 1984; 12: 227
- Barlow R. B., McLeod L. J. Br. J. Pharmacol. 1969; 35: 161–174
- Christensen H. E., Luginbyhl T. T. The Toxic Substances List. USDHEW, Rockville, MD 1974; 61
- The Merck Index. 10th Edition, M. Windholy, S. Budauari. Merck & Co., Inc., Rahway, NJ 1983; 963
- Barbieri R. L., Gochberg J., Ryan K. J. J. Clin. Invest. 1986; 77: 1727–1733
- Gullino P. M., Pettigrew H. M., Grantham F. H. J. Nal. Cancer Inst. 1975; 54: 401–409
- Arafah M., Gullino P. M., Manni A., Pearson O. H. Cancer Res. 1980; 40: 4628–4630
- Lesko S. M., Rosenberg L., Kaufman D. W., Helmrich S. P., Miller D. R., Strom B., Schottenfeld D., Rosenshein N. B., Knapp R. C., Lewis J., Shapiro S. N. Engl. J. Med. 1985; 313: 593–596
- Willett W., Stampfer M. J., Bain C., Lipnick R., Speizer F. E., Rosner B., Cramer D., Hennekens C. H. Amer. J. Epidemiol. 1983; 117: 651–658